Urgent.News

What's breaking now, across thousands of outlets.

Tech

Decreased astrocytic CCL5 by <i>Mir324</i> ameliorates ischemic stroke injury via the CCR5/ERK/CREB pathway

Following ischemic stroke, Ccl5 mRNA expression increased, while Mir324 expression decreased in the peri-infarct cortex of middle cerebral artery occlusion (MCAO) mice. However, the roles of CCL5 and Mir324 in stroke remained largely unclear. Here, we show that inhibiting CCL5 using antibodies or Mir324 not only reduced infarct area and preserved neurological function in MCAO mice but also…

A recent study explores how reducing a specific molecule can help lessen the damage caused by ischemic stroke. Researchers found that decreased levels of CCL5 and increased levels of Mir324 in the brain tissue after a stroke led to better outcomes for the mice. By inhibiting CCL5, either through antibodies or Mir324, they observed a decrease in the size of the stroke-related area and improved neurological function in the affected mice.

This approach also helped protect the neurons and dendritic structures, maintaining their density. In experiments using astrocyte-neuron co-culture systems, the same treatment resulted in a reduction of neuronal apoptosis and preserved dendritic structures. Furthermore, the study found that CCL5 suppression activated the ERK/CREB pathway, both in vivo and in vitro.

The researchers also confirmed these findings with Maraviroc, a CCR5 antagonist, which similarly reduced infarct size, decreased neuronal apoptosis, and upregulated the ERK/CREB pathway in neurons treated with oxygen-glucose deprivation. By targeting the CCL5 pathway through Mir324, this research suggests a promising therapeutic strategy for mitigating the effects of ischemic stroke by modulating the neuronal CCR5/ERK/CREB pathway.

Written by urgent.news from eLife's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at elifesciences.org →

More in Tech

More from Thursday 19 November →